Tag Archives: BÜHLMANN

BÜHLMANN As Gold Sponsor Of The 5th Santorini Pharmacogenetics Conference

Functional Genomics Towards Personalized Health Care The 5th Santorini Conference will take place in Thira, Greece, on September 30th , October 1st and 2nd , 2010. This meeting, held and organized by Biologie prospective and Nancy University cardiovascular genetics team, is an excellent opportunity for scientists, researchers, clinical chemists, physicians, and pharmacologists to present their

Continue Reading →

BÜHLMANN Italia Srl Goes Live January 1st, 2010

BÜHLMANN Laboratories AG is proud to introduce its latest sister company BUHLMANN Italia srl, to go live on January 1st, 2010. The new company will serve all of the BÜHLMANN customers in Italy and significantly strengthen the presence of BÜHLMANN in the Italian market. Dr.ssa Daniela Maioli, Director Marketing&Sales of BUHLMANN Italia srl: “The new

Continue Reading →

BÜHLMANN 1st Participation At Arab Health, Dubai

BÜHLMANN Laboratories AG participates at the upcoming Arab Health in Dubai, 25 – 28 January 2010 (http://www.arabhealthonline.com), together with its distributor for the Middle East, Bioactiva Diagnostica. This participation is a unique chance to get first hand information and support for BÜHLMANN Products. We invite customers to visit us at the Bioactiva Diagnostics Booth in

Continue Reading →

Press Release: BÜHLMANN And Dr. Arne Roseth Agree On Medical Advisership

BÜHLMANN Laboratories AG, Basel, Switzerland, announced today to have signed a Medical Adviser Agreement with Dr. Arne Roseth, Oslo, Norway, in order to support BÜHLMANN’s global initiative to promote fecal Calprotectin in diagnosis and therapy follow up of inflammatory conditions of the intestine. Dr. Roseth is a US-Norwegian gastroenterologist with more than 15 years of

Continue Reading →